NCT07097961 Paediatric Post-TB Pulmonary Rehab Study
| NCT ID | NCT07097961 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Iowa |
| Condition | Tuberculosis in Children |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2025-07-29 |
| Primary Completion | 2026-02-23 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2025-07-29 with a primary completion date of 2026-02-23.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to learn if a home-based pulmonary rehabilitation program is feasible and acceptable for children ages 6-15 who have recently completed treatment for pulmonary tuberculosis. The main questions it aims to answer are: Can children and caregivers follow a 6-week rehabilitation program? Is the program acceptable and feasible for children and caregivers? Researchers will also explore preliminary changes in walking distance and quality of life. Participants will: Attend a clinic visit for baseline testing, including a 6-minute walk test (6MWT) and the St. George's Respiratory Questionnaire (SGRQ) Receive exercise instructions and a pedometer Complete home-based walking and wall sit exercises twice per week for 6 weeks Receive weekly follow-up from study staff (by phone or home visit) Return to clinic at 6 weeks for follow-up testing
Eligibility Criteria
Inclusion Criteria: * Aged 6-17 years * Previously diagnosed with post-TB lung disease, * Willing to remain in the study catchment area during the study period * Able to participate in mild-to-moderate physical activity (late inclusion criterion) Exclusion Criteria: * Currently participating in another rehabilitation program * Residence outside the Kampala metropolitan area * Active respiratory infection (late exclusion criterion)
Contact & Investigator
Greta L Becker, MD
PRINCIPAL INVESTIGATOR
University of Iowa
Frequently Asked Questions
Who can join the NCT07097961 clinical trial?
This trial is open to participants of all sexes, aged 6 Years or older, up to 17 Years, studying Tuberculosis in Children. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07097961 currently recruiting?
Yes, NCT07097961 is actively recruiting participants. Contact the research team at greta-becker@uiowa.edu for enrollment information.
Where is the NCT07097961 trial being conducted?
This trial is being conducted at Kampala, Uganda.
Who is sponsoring the NCT07097961 clinical trial?
NCT07097961 is sponsored by University of Iowa. The principal investigator is Greta L Becker, MD at University of Iowa. The trial plans to enroll 40 participants.